Neuphoria Therapeutics Inc (NEUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 09-2023 | 06-2023 | 12-2022 | 06-2022 | 06-2021 | |
| Operating Expenses | 5,468 | 0 | 0 | 0 | 0 |
| Operating Income | -5,468 | N/A | N/A | N/A | N/A |
| Other Income | -40 | 0 | 0 | 0 | 0 |
| Pre-tax Income | -5,507 | 0 | 0 | 0 | 0 |
| Income Tax | -35 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -5,473 | N/A | N/A | N/A | N/A |
| Net Income | $-5,473 | $N/A | $N/A | $N/A | $N/A |
| EPS Basic Continuous Ops | -7.90 | N/A | N/A | N/A | N/A |
| EPS Diluted Continuous Ops | -7.90 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-5,302 | $N/A | $N/A | $N/A | $N/A |